logo
welcome
SeekingAlpha

SeekingAlpha

SciSparc gets U.S. FDA nod to begin phase 2 trial of Tourette Syndrome candidate

SeekingAlpha
Summary
Nutrition label

76% Informative

SCI-110 is a combination of dronabinol, a synthetic form of tetrahydrocannabinol ( THC ) with the endocannabinoid palmitoylethanolamide ( PEA ) The therapy is designed to stimulate cannabinoid receptors across the Central Nervous System .

VR Score

79

Informative language

79

Neutral language

95

Article tone

formal

Language

English

Language complexity

65

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links